Literature DB >> 23689977

Characterization of the Yoshida sarcoma: a model of cancer cachexia.

Mary Ann Honors1, Kimberly P Kinzig.   

Abstract

PURPOSE: Cancer cachexia contributes significantly to morbidity and mortality in individuals with cancer. Currently, the mechanisms contributing to the development of cachexia are largely unknown, leading to a paucity of treatment and prevention options. Animal models are necessary in determining causal mechanisms and in testing potential treatments. While the Yoshida sarcoma has been utilized for more than 50 years, the cachexia syndrome produced by this model has not been well characterized in the literature.
METHODS: Tumor allografts were subcutaneously implanted in male Sprague Dawley rats (n = 16) and allowed to grow for 23 days. Control animals (n = 16) received a sham surgery. All rats were monitored daily for the presence of hallmark cachexia symptoms.
RESULTS: The results demonstrate the presence of decreased body weight gain, as well as lower levels of body adiposity and skeletal muscle mass, in tumor-bearing animals, as compared to controls.
CONCLUSIONS: While a large tumor burden was reached, the extent of cachexia was similar to that which is observed in many individuals with cancer cachexia. Future experiments utilizing this model are encouraged to identify mechanisms and effective treatment and prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689977      PMCID: PMC3780404          DOI: 10.1007/s00520-013-1839-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  27 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

Review 2.  Cachexia in cancer patients.

Authors:  Michael J Tisdale
Journal:  Nat Rev Cancer       Date:  2002-11       Impact factor: 60.716

Review 3.  Protein degradation by the ubiquitin-proteasome pathway in normal and disease states.

Authors:  Stewart H Lecker; Alfred L Goldberg; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2006-05-31       Impact factor: 10.121

Review 4.  The cancer cachexia syndrome: a review of metabolic and clinical manifestations.

Authors:  Dema Halasa Esper; Wael A Harb
Journal:  Nutr Clin Pract       Date:  2005-08       Impact factor: 3.080

Review 5.  Cancer cachexia.

Authors:  J N Gordon; S R Green; P M Goggin
Journal:  QJM       Date:  2005-10-07

Review 6.  Anorexia and cancer in animals and man.

Authors:  S Garattini; A Bizzi; M G Donelli; A Guaitani; R Samanin; F Spreafico
Journal:  Cancer Treat Rev       Date:  1980-09       Impact factor: 12.111

7.  Hypercatabolism and hypermetabolism in wasting states.

Authors:  Vickie E Baracos
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2002-05       Impact factor: 4.294

8.  Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy.

Authors:  Joanne L Hutton; Lisa Martin; Catherine J Field; Wendy V Wismer; Eduardo D Bruera; Sharon M Watanabe; Vickie E Baracos
Journal:  Am J Clin Nutr       Date:  2006-11       Impact factor: 7.045

9.  Mechanism of increased lipolysis in cancer cachexia.

Authors:  Thorhallur Agustsson; Mikael Rydén; Johan Hoffstedt; Vanessa van Harmelen; Andrea Dicker; Jurga Laurencikiene; Bengt Isaksson; Johan Permert; Peter Arner
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

10.  Day-night pattern of energy expenditure and body temperature in cachectic tumour-bearing rats.

Authors:  H Oudart; A Malan; Y Maho; A Geloen
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

View more
  3 in total

1.  Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.

Authors:  Paul T Winnard; Santosh K Bharti; Marie-France Penet; Radharani Marik; Yelena Mironchik; Flonne Wildes; Anirban Maitra; Zaver M Bhujwalla
Journal:  Cancer Res       Date:  2015-12-30       Impact factor: 12.701

2.  Chronic exendin-4 treatment prevents the development of cancer cachexia symptoms in male rats bearing the Yoshida sarcoma.

Authors:  Mary Ann Honors; Kimberly P Kinzig
Journal:  Horm Cancer       Date:  2013-10-08       Impact factor: 3.869

3.  Diet-induced obesity and insulin resistance spur tumor growth and cancer cachexia in rats bearing the Yoshida sarcoma.

Authors:  Mary Ann Honors; Kimberly P Kinzig
Journal:  Nutr Cancer       Date:  2014-06-04       Impact factor: 2.900

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.